What started out as an effort by Google to crack down on predatory stem cell clinics advertising bogus therapies seems to be getting diluted. Now the concern is whether that will make it easier for these clinics to lure unsuspecting patients to pay good money for bad treatments? A little background might help here. For … Continue reading Google eases ban on ads for stem cell therapies
Stem cells
It’s hard to be modest when people keep telling you how good you are
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST I have a confession. Deep down I’m shallow. So when something I am part of is acknowledged as one of the best, I delight in it (my fellow bloggers Katie and Esteban also delight in it, I am just more shameless about letting everyone know.) And … Continue reading It’s hard to be modest when people keep telling you how good you are
Stem cell agency invests in therapy using killer cells to target colorectal, breast and ovarian cancers
While there have been some encouraging advances in treating cancer in recent decades, there are still many cancers that either resist treatment or recur after treatment. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investing in a therapy targeting some of these hard-to-treat tumors. BioEclipse Therapeutics Inc. was awarded nearly … Continue reading Stem cell agency invests in therapy using killer cells to target colorectal, breast and ovarian cancers
Chance discovery could lead to a treatment for skin ulcers
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Dr. Antoni Ribas in his research lab on the UCLA Campus: Photo courtesy Ann Johansson When UCLA's Dr. Antoni Ribas was researching a potential therapy for melanoma, a form of skin cancer, he stumbled upon something unexpected. That unexpected discovery has now resulted in him getting … Continue reading Chance discovery could lead to a treatment for skin ulcers
Promoting stem cell therapies, racial justice, and fish breeding
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Jan Nolta, PhD, in her lab at UC Davis; Photo courtesy UC Davis Working at CIRM, you get to meet many remarkable people, and Jan Nolta, PhD, certainly falls into that category. Jan is the Director of the Stem Cell Program at UC Davis School of Medicine. She … Continue reading Promoting stem cell therapies, racial justice, and fish breeding
HOPE for patients with a muscle destroying disease
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Caleb Sizemore, photo by Todd Dubnicoff Caleb Sizemore says growing up with Duchenne’s Muscular Dystrophy (DMD) was tough. The disease is a rare genetic disorder that slowly destroys a person’s muscles, impairing their ability to walk or breathe. Eventually it attacks the heart leading to premature … Continue reading HOPE for patients with a muscle destroying disease
Stem Cell Agency Hires New Vice President of Medical Affairs & Policy
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Dr. Sean Turbeville Sean Turbeville PhD. is joining the California Institute for Regenerative Medicine (CIRM) as the Vice President of Medical Affairs and Policy. Dr. Turbeville has almost 20 years of experience in Medical Affairs, creating strategies and teams for biopharma and digital healthcare companies. He … Continue reading Stem Cell Agency Hires New Vice President of Medical Affairs & Policy
Joining the movement to fight rare diseases
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST It’s hard to think of something as being rare when it affects up to 30 million Americans and 300 million people worldwide. But the truth is there are more than 6,000 conditions – those affecting 200,000 people or fewer – that are considered rare. Today, … Continue reading Joining the movement to fight rare diseases
It’s nice to be appreciated
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Photo: courtesy City of Hope No one likes to be taken for granted, to feel that people only like you because you have scads of cash and they want some of it. That’s why it’s so lovely when you feel you are appreciated because of all … Continue reading It’s nice to be appreciated
CIRM-supported therapy for blood cancers gets FDA fast track
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST People often complain about how long it can take to turn a scientific discovery into an approved therapy for patients. And they’re right. It can take years, decades even. But for Immune-Onc Therapeutics the path to FDA approval may just have been shortened. Back in April … Continue reading CIRM-supported therapy for blood cancers gets FDA fast track
The Stem Cellar 